vimarsana.com
Home
Live Updates
Vitro S.A. sells Cytognos to BD to prioritize the market lau
Vitro S.A. sells Cytognos to BD to prioritize the market lau
Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms
Cytognos divestment is a first strategic step aimed at positioning Vitro as a new worldwide diagnostic player in their key market segments SEVILLE, Spain, Feb. 04, 2022 /PRNewswire/ --
Related Keywords
Granada ,
Andalucísp ,
Spain ,
Istanbul ,
Turkey ,
Lisbon ,
Lisboa ,
Portugal ,
Salamanca ,
Castillay Leóp ,
Valencia ,
Carabobo ,
Venezuela ,
Madrid ,
Spanish ,
Becton Dickinson ,
Javier Fernandez ,
Women Health ,
Lazard ,
Invitro ,
Cells ,
Ytognos ,
Wprioritize ,
Market ,
Launch ,
Disruptive ,
Olecular ,
Iology ,
Anatomic ,
Pathology ,
Iagnostic ,
Platforms ,